Subscribe To
Scilex holding company, a majority-owned subsidiary of sorrento therapeutics, inc., acquires rights to fda-approved elyxyb™ in the u.s. and canada for the acute treatment of migraine
ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in...
February 12, 2023, 11:48 pm
Science 37 reports inducement grants under nasdaq listing rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today ann...
February 10, 2023, 10:18 pm
Humbl launches mobile wallet with digital assets, search engine and social media functionality in one application
San Diego, California, Feb. 10, 2023 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC: HMBL) (the “Company”) is pleased to announce that HUMBL® has delivere...
February 10, 2023, 2:51 pm
Vyne therapeutics announces reverse stock split
Common stock expected to begin trading on split-adjusted basis on February 13, 2023 BRIDGEWATER, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) — VYNE Therape...
February 10, 2023, 1:00 pm
Micron suspends executive bonuses. the stock was upgraded, too.
Micron said late Thursday a board committee has approved plans to cut certain executives' salaries and ...
February 10, 2023, 9:15 am
China approves 87 new video games including titles by tencent and alibaba
China's video games regulator on Friday approved 87 new video games for the month of Feburary including...
February 10, 2023, 8:15 am
Phathom's stock falls after receiving fda letters
Shares of Phathom Pharmaceuticals Inc. PHAT, -0.60% tumbled about 23% in premarket trading on Friday, the day after the company said it received compl...
February 10, 2023, 7:59 am
4 warren buffett-approved dividend stocks to buy today
These dividend stocks could be excellent sources of passive income for long-term investors....
February 10, 2023, 5:05 am
Cts corporation board of directors authorizes new share repurchase plan
LISLE, Ill., Feb. 09, 2023 (GLOBE NEWSWIRE) — The Board of Directors of CTS Corporation (NYSE: CTS) approve<...
February 10, 2023, 12:49 am
Rpt realty declares and raises common share dividend by 8% and declares preferred share dividend
NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) — RPT Realty (NYSE:RPT) (“RPT” or the “Company”) announced today that its Board of Trustees declare...
February 9, 2023, 9:20 pm
Robinhood q4 crypto revenue dips, board approves buyback of sbf stocks
Robinhood Markets, Inc. (NASDAQ: HOOD) announced its financials for the fourth quarter of 2022, with a 5 percent increase in total net revenue to $...
February 9, 2023, 10:06 am
Galapagos shares down after announcing clinical-trial miss for crohn's disease
U.S.-listed shares of Galapagos GLPG, +0.41% were down 8.9% in premarket trading on Thursday, the day after the company said an experimental treatment...
February 9, 2023, 8:35 am
Pepsico q4 earnings beat estimates as guidance falls short; board approves 10% dividend hike
PepsiCo Inc. PEP, -0.23% said Thursday it had net income of $518 million, or 37 cents a share, in the fourth quarter, down from $1.322 billion, or 95 ...
February 9, 2023, 6:16 am
Eylea® (aflibercept) injection approved as the first pharmacologic treatment for preterm infants with retinopathy of prematurity (rop) by the fda
ROP is a leading cause of childhood blindness worldwide EYLEA now approved to treat five retinal condit...
February 8, 2023, 11:45 pm
Cara therapeutics announces results from the komfort phase 2 trial of oral difelikefalin for the treatment of pruritus in notalgia paresthetica published in the new england journal of medicine
Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an app...
February 8, 2023, 10:00 pm
Lithium americas remains a ‘buy' as favourable ruling will help unlock general motors' $650m investment, stifel analysts say
Lithium Americas Corp (TSX:LAC, NYSE:LAC) has received a favourable ruling from the US District Court regarding its Thacker Pass project in Nevada's H...
February 8, 2023, 12:11 pm
Urogen: struggling with revenue and with cash runway
UroGen has an approved drug and a platform. However, there's not much growth in revenue....
February 8, 2023, 4:04 am
Lithium americas: thacker pass approved, now look south for production
On Feb 6, 2023, Lithium Americas Corp.'s Thacker Pass mine was finally approved after a lengthy court t...
February 7, 2023, 3:47 pm
Adicet bio: searching for upside in cell therapeutics
Biotechs developing CAR-T cell therapies have seen their valuations plummet in 2022 - making them an intriguing speculative buy opportunity in 2023. T...
February 7, 2023, 2:24 pm
Outlook therapeutics® to present at the svb securities global biopharma conference
– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET – ISELIN, N.J., F...
February 7, 2023, 1:05 pm